Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Chemours (CC) over the last 8 years, with Q3 2025 value amounting to $5.0 million.

  • Chemours' Share-based Compensation changed 0.0% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 2500.0%. This contributed to the annual value of $15.0 million for FY2024, which is 1666.67% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Share-based Compensation is $5.0 million, which was down 0.0% from $7.0 million recorded in Q2 2025.
  • Chemours' Share-based Compensation's 5-year high stood at $12.0 million during Q1 2021, with a 5-year trough of $1.0 million in Q1 2024.
  • Its 5-year average for Share-based Compensation is $5.7 million, with a median of $5.0 million in 2023.
  • Per our database at Business Quant, Chemours' Share-based Compensation skyrocketed by 70000.0% in 2021 and then plummeted by 7500.0% in 2024.
  • Over the past 5 years, Chemours' Share-based Compensation (Quarter) stood at $10.0 million in 2021, then crashed by 70.0% to $3.0 million in 2022, then soared by 66.67% to $5.0 million in 2023, then plummeted by 40.0% to $3.0 million in 2024, then soared by 66.67% to $5.0 million in 2025.
  • Its Share-based Compensation stands at $5.0 million for Q3 2025, versus $7.0 million for Q2 2025 and $5.0 million for Q1 2025.